Literature DB >> 25265868

Morphology of gold nanoparticles determined by full-curve fitting of the light absorption spectrum. Comparison with X-ray scattering and electron microscopy data.

Kostyantyn Slyusarenko1, Benjamin Abécassis, Patrick Davidson, Doru Constantin.   

Abstract

UV-Vis absorption spectroscopy is frequently used to characterize the size and shape of gold nanoparticles. We present a full-spectrum model that yields reliable results for the commonly encountered case of mixtures of spheres and rods in varying proportions. We determine the volume fractions of the two populations, the aspect ratio distribution of the nanorods (average value and variance) and the interface damping parameter. We validate the model by checking the fit results against small-angle X-ray scattering and transmission electron microscopy data and show that correctly accounting for the polydispersity in aspect ratio is essential for a quantitative description of the longitudinal plasmon peak.

Year:  2014        PMID: 25265868     DOI: 10.1039/c4nr04155k

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  4 in total

1.  Why the aspect ratio? Shape equivalence for the extinction spectra of gold nanoparticles.

Authors:  Doru Constantin
Journal:  Eur Phys J E Soft Matter       Date:  2015-11-20       Impact factor: 1.890

2.  Knockdown of glutamate cysteine ligase catalytic subunit by siRNA causes the gold nanoparticles-induced cytotoxicity in lung cancer cells.

Authors:  Min Liu; Yunxue Zhao; Xiumei Zhang
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

3.  Determining the morphology and concentration of core-shell Au/Ag nanoparticles.

Authors:  Jieli Lyu; Valérie Geertsen; Cyrille Hamon; Doru Constantin
Journal:  Nanoscale Adv       Date:  2020-09-02

4.  Albumen Transport to Bruch's Membrane and RPE by Choriocapillaris Caveolae.

Authors:  Masataka Nakanishi; Rhonda Grebe; Imran A Bhutto; Malia Edwards; D Scott McLeod; Gerard A Lutty
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04-01       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.